Results 71 to 80 of about 665,601 (180)
Benign by design: A paradigm shift in cosmetic ingredient development
Benign by design strategies enable the creation of biodegradable cosmetic ingredients, reducing environmental persistence while maintaining the intended biological activity. This work compiles design rules and tools to guide the development of more sustainable molecules for the cosmetics industry.
Sandra Mota +3 more
wiley +1 more source
1,6-Cyclophellitol Cyclosulfates: A New Class of Irreversible Glycosidase Inhibitor [PDF]
The essential biological roles played by glycosidases, coupled to the diverse therapeutic benefits of pharmacologically targeting these enzymes, provide considerable motivation for the development of new inhibitor classes.
Breen, I.Z. +38 more
core +1 more source
International audienceCapitalizing on a previously developed Staudinger/azaWittig/Grignard (SAWG)-ring contraction sequence that furnished protected six-membered L-iminosugar C,C-glycosides bearing an allyl group and various substituents at the ...
Désiré, Jérôme +11 more
core +1 more source
Parasitoid wasps deploy maternal and embryonic factors to reprogramme host physiology. Venom, calyx fluid, polydnaviruses, teratocytes and larval secretions act in a coordinated, compartmentalised manner. Host‐regulation factors are promising sources of insecticidal, antimicrobial and bioinspired translational molecules.
Ciro Pedro G. Pinto +2 more
wiley +1 more source
This study evaluated serum miRNAs as biomarkers in adult patients with SPIDDM. Serum miRNAs were measured at the time of SPIDDM (probable) diagnosis, and miR‐150‐5p was inversely associated with CPI at the last outpatient visit, suggesting its potential utility for predicting subsequent insulin secretory decline.
Hideyuki Okuma +4 more
wiley +1 more source
Studies into the Stereo Selective Synthesis of Glycosidase Inhibitors.
The goal of our research was to develop an enantiopure glycosidase inhibitor. Glycosidase inhibitors are similar in structure to sugar molecules, and therefore lock up enzymes used in the consumption of sugars for respiration.
Vachher-Gnanathurai, Amit
core
ABSTRACT Modern biopharmaceutical manufacturing requires purification platforms capable of processing structurally and functionally diverse products while addressing the challenge of removing persistent and high‐risk host cell proteins (HCPs).
Wenning Chu +23 more
wiley +1 more source
Mannostatin A (1) is a new cyclitol inhibitor of glycoprotein processing. 2-Epimannostatin A (12) and its enantiomer (13) as well as their positional isomers (14, 15) were designed for probing structure−activity relationships in this class of ...
Hayamitsu Adachi (1666837) +4 more
core +2 more sources
Cell-penetrating peptide (CPP) is a promising cargo for delivering bioactive molecules. In this study, the N terminus of VP1 from chicken anemia virus, designated as CVP1, was found to carry enriched arginine residues with α-helix.
Gaowei Hu +9 more
doaj +1 more source
Synthesis of glycogen‐like tetrasaccharides allowed the design of an integrated HILIC‐MS/cyclic ion mobility MS workflow to characterize glycosidase specificity. HsGDE selectively hydrolyzed α‐1,6 branches, whereas yeast α‐1,4‐glucosidase preferentially cleaved α‐1,4 linkages, and the rice enzyme showed broader regioisomeric activity.
Delphine Carry +12 more
wiley +1 more source

